Your browser doesn't support javascript.
loading
A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection.
Ichihara, Eiki; Hasegawa, Kou; Kudo, Kenichiro; Tanimoto, Yasushi; Nouso, Kazuhiro; Oda, Naohiro; Mitsumune, Sho; Yamada, Haruto; Takata, Ichiro; Hagiya, Hideharu; Mitsuhashi, Toshiharu; Taniguchi, Akihiko; Toyooka, Shinichi; Tsukahara, Kohei; Aokage, Toshiyuki; Tsukahara, Hirokazu; Kiura, Katsuyuki; Maeda, Yoshinobu.
Afiliação
  • Ichihara E; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Hasegawa K; Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Kudo K; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Tanimoto Y; Department of Allergy and Respiratory Medicine, National Hospital Organization Minami-Okayama Medical Center, Japan.
  • Nouso K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Oda N; Department of Internal Medicine, Fukuyama City Hospital, Fukuyama, Japan.
  • Mitsumune S; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Yamada H; Department of Infectious Disease, Okayama City Hospital, Okayama, Japan.
  • Takata I; Department of Internal Medicine, Fukuyama City Hospital, Fukuyama, Japan.
  • Hagiya H; Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Mitsuhashi T; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Taniguchi A; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Toyooka S; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Tsukahara K; Department of Emergency, Critical Care and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Aokage T; Department of Emergency, Critical Care and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Tsukahara H; Department of Pediatrics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Kiura K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Maeda Y; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
PLoS One ; 18(10): e0287501, 2023.
Article em En | MEDLINE | ID: mdl-37883347

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diterpenos / COVID-19 Limite: Aged / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diterpenos / COVID-19 Limite: Aged / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão